Skip to main content
TipRanks
Go Ultimate75% OFF

Joel Michael Maryles Insider Profile

4 Followers

Joel Michael Maryles, Director at Chemomab Therapeutics, holds 1.43K shares in Chemomab Therapeutics (Ticker: CMMB). Most recently, Joel Michael Maryles Bought 433 shares of Chemomab Therapeutics on May 25, 2022 for an estimated value of $1.25K.

Joel Michael Maryles's Trading History

CMMB
Chemomab Therapeutics
May 25, 2022DirectorInformative Buy1.25K$2.32K
CMMB
Insider Shares: 1.43K (0.01%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
May 25, 2022Informative Buy$1.25K433$2.88-43.20%
Mar 21, 2022Informative Buy$4.34K1,000$4.34-66.80%

You May Also Like

Joel Michael Maryles insider profile FAQ

What is the percentage of profitable transactions made by Joel Michael Maryles?
The percentage of profitable transactions made by Joel Michael Maryles is 0%.
What is the average return per transaction made by Joel Michael Maryles?
The average return per transaction made by Joel Michael Maryles is -55.00%.
What stocks does Joel Michael Maryles hold?
Joel Michael Maryles holds: CMMB stocks.
What was Joel Michael Maryles’s latest transaction?
Joel Michael Maryles’s latest transaction was an Informative Buy of $1.25K.
What was Joel Michael Maryles's most profitable transaction?
Joel Michael Maryles’s most profitable transaction was an Informative Buy of CMMB stock on May 25, 2022. The return on the trade was -43.20%.
What is Joel Michael Maryles's role in Chemomab Therapeutics?
Joel Michael Maryles's role in Chemomab Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.